{"metadata":{"kernelspec":{"name":"python3","display_name":"Python 3","language":"python"},"language_info":{"name":"python","version":"3.11.13","mimetype":"text/x-python","codemirror_mode":{"name":"ipython","version":3},"pygments_lexer":"ipython3","nbconvert_exporter":"python","file_extension":".py"},"kaggle":{"accelerator":"none","dataSources":[],"isInternetEnabled":true,"language":"python","sourceType":"notebook","isGpuEnabled":false}},"nbformat_minor":4,"nbformat":4,"cells":[{"cell_type":"markdown","source":"## Section 1: Setup","metadata":{}},{"cell_type":"code","source":"import os\nfrom kaggle_secrets import UserSecretsClient\n\ntry:\n    GOOGLE_API_KEY = UserSecretsClient().get_secret(\"GOOGLE_API_KEY\")\n    os.environ[\"GOOGLE_API_KEY\"] = GOOGLE_API_KEY\n    print(\"âœ… Gemini API key setup complete.\")\nexcept Exception as e:\n    print(\n        f\"ðŸ”‘ Authentication Error: Please make sure you have added 'GOOGLE_API_KEY' to your Kaggle secrets. Details: {e}\"\n    )","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-21T17:37:33.005943Z","iopub.execute_input":"2025-11-21T17:37:33.006309Z","iopub.status.idle":"2025-11-21T17:37:33.192422Z","shell.execute_reply.started":"2025-11-21T17:37:33.006283Z","shell.execute_reply":"2025-11-21T17:37:33.191586Z"}},"outputs":[{"name":"stdout","text":"âœ… Gemini API key setup complete.\n","output_type":"stream"}],"execution_count":1},{"cell_type":"markdown","source":"### Import ADK components","metadata":{}},{"cell_type":"code","source":"from typing import Any, Dict\n\nfrom google.adk.agents import Agent, LlmAgent\nfrom google.adk.apps.app import App, EventsCompactionConfig\nfrom google.adk.models.google_llm import Gemini\nfrom google.adk.sessions import DatabaseSessionService\nfrom google.adk.sessions import InMemorySessionService\nfrom google.adk.runners import Runner\nfrom google.adk.tools.tool_context import ToolContext\nfrom google.genai import types\n\nprint(\"ADK components imported successfully.\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-21T17:37:55.871293Z","iopub.execute_input":"2025-11-21T17:37:55.872226Z","iopub.status.idle":"2025-11-21T17:38:42.028059Z","shell.execute_reply.started":"2025-11-21T17:37:55.872196Z","shell.execute_reply":"2025-11-21T17:38:42.027373Z"}},"outputs":[{"name":"stdout","text":"ADK components imported successfully.\n","output_type":"stream"}],"execution_count":2},{"cell_type":"markdown","source":"### Helper functions","metadata":{}},{"cell_type":"code","source":"# Define helper functions that will be reused throughout the notebook\nasync def run_session(\n    runner_instance: Runner,\n    user_queries: list[str] | str = None,\n    session_name: str = \"default\",\n):\n    print(f\"\\n ### Session: {session_name}\")\n\n    # Get app name from the Runner\n    app_name = runner_instance.app_name\n\n    # Attempt to create a new session or retrieve an existing one\n    try:\n        session = await session_service.create_session(\n            app_name=app_name, user_id=USER_ID, session_id=session_name\n        )\n    except:\n        session = await session_service.get_session(\n            app_name=app_name, user_id=USER_ID, session_id=session_name\n        )\n\n    # Process queries if provided\n    if user_queries:\n        # Convert single query to list for uniform processing\n        if type(user_queries) == str:\n            user_queries = [user_queries]\n\n        # Process each query in the list sequentially\n        for query in user_queries:\n            print(f\"\\nUser > {query}\")\n\n            # Convert the query string to the ADK Content format\n            query = types.Content(role=\"user\", parts=[types.Part(text=query)])\n\n            # Stream the agent's response asynchronously\n            async for event in runner_instance.run_async(\n                user_id=USER_ID, session_id=session.id, new_message=query\n            ):\n                # Check if the event contains valid content\n                if event.content and event.content.parts:\n                    # Filter out empty or \"None\" responses before printing\n                    if (\n                        event.content.parts[0].text != \"None\"\n                        and event.content.parts[0].text\n                    ):\n                        print(f\"{MODEL_NAME} > \", event.content.parts[0].text)\n    else:\n        print(\"No queries!\")\n\n\nprint(\"Helper functions defined.\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-21T17:38:54.362670Z","iopub.execute_input":"2025-11-21T17:38:54.364525Z","iopub.status.idle":"2025-11-21T17:38:54.372385Z","shell.execute_reply.started":"2025-11-21T17:38:54.364492Z","shell.execute_reply":"2025-11-21T17:38:54.371582Z"}},"outputs":[{"name":"stdout","text":"Helper functions defined.\n","output_type":"stream"}],"execution_count":3},{"cell_type":"markdown","source":"### Configure Retry Options","metadata":{}},{"cell_type":"code","source":"retry_config = types.HttpRetryOptions(\n    attempts=5,  # Maximum retry attempts\n    exp_base=7,  # Delay multiplier\n    initial_delay=1,\n    http_status_codes=[429, 500, 503, 504],  # Retry on these HTTP errors\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-21T17:38:59.767360Z","iopub.execute_input":"2025-11-21T17:38:59.767671Z","iopub.status.idle":"2025-11-21T17:38:59.772451Z","shell.execute_reply.started":"2025-11-21T17:38:59.767627Z","shell.execute_reply":"2025-11-21T17:38:59.771467Z"}},"outputs":[],"execution_count":4},{"cell_type":"markdown","source":"---\n## Section 2: Session Management\n**Session**\n\nA session is a container for conversations. It encapsulates the conversation history in a chronological manner and also records all tool interactions and responses for a single, continuous conversation. A session is tied to a user and agent; it is not shared with other users. Similarly, a session history for an Agent is not shared with other Agents.\n","metadata":{}},{"cell_type":"markdown","source":"### Implementing Stateful Agent\n\nLet's build stateful agent, that can remember and have constructive conversations. ","metadata":{}},{"cell_type":"code","source":"APP_NAME = \"default\"  # Application\nUSER_ID = \"default\"  # User\nSESSION = \"default\"  # Session\n\nMODEL_NAME = \"gemini-2.5-flash-lite\"\n\n\n# Step 1: Create the LLM Agent\nroot_agent = Agent(\n    model=Gemini(model=\"gemini-2.5-flash-lite\", retry_options=retry_config),\n    name=\"text_chat_bot\",\n    description=\"A text chatbot\",  # Description of the agent's purpose\n)\n\n# Step 2: Set up Session Management\n# InMemorySessionService stores conversations in RAM (temporary)\nsession_service = InMemorySessionService()\n\n# Step 3: Create the Runner\nrunner = Runner(agent=root_agent, app_name=APP_NAME, session_service=session_service)\n\nprint(\"Stateful agent initialized!\")\nprint(f\"   - Application: {APP_NAME}\")\nprint(f\"   - User: {USER_ID}\")\nprint(f\"   - Using: {session_service.__class__.__name__}\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-21T18:12:11.530307Z","iopub.execute_input":"2025-11-21T18:12:11.533192Z","iopub.status.idle":"2025-11-21T18:12:11.549923Z","shell.execute_reply.started":"2025-11-21T18:12:11.533156Z","shell.execute_reply":"2025-11-21T18:12:11.548725Z"}},"outputs":[{"name":"stdout","text":"Stateful agent initialized!\n   - Application: default\n   - User: default\n   - Using: InMemorySessionService\n","output_type":"stream"}],"execution_count":5},{"cell_type":"markdown","source":"### Testing the Stateful Agent","metadata":{}},{"cell_type":"code","source":"await run_session(\n    runner,\n    [\n        \"Hi, I am Yadnywalky! What is the capital of India?\",\n        \"Hello! What is my name?\",  \n    ],\n    \"stateful-agentic-session\",\n)","metadata":{"lines_to_next_cell":2,"trusted":true,"execution":{"iopub.status.busy":"2025-11-21T18:13:20.592597Z","iopub.execute_input":"2025-11-21T18:13:20.592956Z","iopub.status.idle":"2025-11-21T18:13:22.338488Z","shell.execute_reply.started":"2025-11-21T18:13:20.592932Z","shell.execute_reply":"2025-11-21T18:13:22.337575Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: stateful-agentic-session\n\nUser > Hi, I am Yadnywalky! What is the capital of India?\ngemini-2.5-flash-lite >  Hi Yadnywalky! The capital of India is **New Delhi**.\n\nUser > Hello! What is my name?\ngemini-2.5-flash-lite >  You are Yadnywalky!\n","output_type":"stream"}],"execution_count":6},{"cell_type":"markdown","source":"**Success!** ðŸŽ‰ The agent remembered your name because both queries were part of the same session. The Runner automatically maintained the conversation history.","metadata":{}},{"cell_type":"markdown","source":"---\n## Section 3: Persistent Sessions with `DatabaseSessionService`\n\nWhile `InMemorySessionService` is great for prototyping, real-world applications need conversations to survive restarts, crashes, and deployments. Let's level up to persistent storage!","metadata":{}},{"cell_type":"markdown","source":"### Implementing Persistent Sessions","metadata":{}},{"cell_type":"code","source":"# Step 1: Create the same agent\nchatbot_agent = LlmAgent(\n    model=Gemini(model=\"gemini-2.5-flash-lite\", retry_options=retry_config),\n    name=\"text_chat_bot\",\n    description=\"A text chatbot with persistent memory\",\n)\n\n# Step 2: Switch to DatabaseSessionService\n# SQLite database will be created automatically\ndb_url = \"sqlite:///my_agent_data.db\"  # Local SQLite file\nsession_service = DatabaseSessionService(db_url=db_url)\n\n# Step 3: Create a new runner with persistent storage\nrunner = Runner(agent=chatbot_agent, app_name=APP_NAME, session_service=session_service)\n\nprint(\"Upgraded to persistent sessions!\")\nprint(f\"   - Database: my_agent_data.db\")\nprint(f\"   - Sessions will survive restarts!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-21T18:17:44.694965Z","iopub.execute_input":"2025-11-21T18:17:44.695414Z","iopub.status.idle":"2025-11-21T18:17:44.839918Z","shell.execute_reply.started":"2025-11-21T18:17:44.695386Z","shell.execute_reply":"2025-11-21T18:17:44.838994Z"}},"outputs":[{"name":"stdout","text":"Upgraded to persistent sessions!\n   - Database: my_agent_data.db\n   - Sessions will survive restarts!\n","output_type":"stream"}],"execution_count":7},{"cell_type":"markdown","source":"### Test Run 1: Verifying Persistence\n\nIn this first test run, I'll start a new conversation with the session ID `test-db-session-01`.","metadata":{}},{"cell_type":"code","source":"await run_session(\n    runner,\n    [\"Hi, I am Yadnywaly! What is the capital of the Japan?\", \"Hello! What is my name?\"],\n    \"test-db-session-01\",\n)","metadata":{"lines_to_next_cell":2,"trusted":true,"execution":{"iopub.status.busy":"2025-11-21T18:19:04.373463Z","iopub.execute_input":"2025-11-21T18:19:04.373816Z","iopub.status.idle":"2025-11-21T18:19:05.640582Z","shell.execute_reply.started":"2025-11-21T18:19:04.373792Z","shell.execute_reply":"2025-11-21T18:19:05.639540Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: test-db-session-01\n\nUser > Hi, I am Yadnywaly! What is the capital of the Japan?\ngemini-2.5-flash-lite >  Hi Yadnywaly! The capital of Japan is Tokyo.\n\nUser > Hello! What is my name?\ngemini-2.5-flash-lite >  Your name is Yadnywaly.\n","output_type":"stream"}],"execution_count":9},{"cell_type":"code","source":"await run_session(\n    runner,\n    [\"What is the capital of India?\", \"Hello! What is my name?\"],\n    \"test-db-session-01\",\n)","metadata":{"lines_to_next_cell":2,"trusted":true,"execution":{"iopub.status.busy":"2025-11-21T18:19:27.390457Z","iopub.execute_input":"2025-11-21T18:19:27.391077Z","iopub.status.idle":"2025-11-21T18:19:28.240605Z","shell.execute_reply.started":"2025-11-21T18:19:27.391050Z","shell.execute_reply":"2025-11-21T18:19:28.239585Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: test-db-session-01\n\nUser > What is the capital of India?\ngemini-2.5-flash-lite >  The capital of India is New Delhi.\n\nUser > Hello! What is my name?\ngemini-2.5-flash-lite >  Your name is Yadnywaly.\n","output_type":"stream"}],"execution_count":10},{"cell_type":"markdown","source":"### Let's verify that the session data is isolated\n\nAs mentioned earlier, a session is private conversation between an Agent and a User . Let's run`run_session` with a different session name `test-db-session-02` to confirm this.\n","metadata":{}},{"cell_type":"code","source":"await run_session(\n    runner, [\"Hello! What is my name?\"], \"test-db-session-02\"\n)  ","metadata":{"lines_to_next_cell":2,"trusted":true,"execution":{"iopub.status.busy":"2025-11-21T18:20:24.126842Z","iopub.execute_input":"2025-11-21T18:20:24.127150Z","iopub.status.idle":"2025-11-21T18:20:24.623836Z","shell.execute_reply.started":"2025-11-21T18:20:24.127131Z","shell.execute_reply":"2025-11-21T18:20:24.622793Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: test-db-session-02\n\nUser > Hello! What is my name?\ngemini-2.5-flash-lite >  I do not have access to your personal information, so I cannot tell you your name. \n\n","output_type":"stream"}],"execution_count":11},{"cell_type":"markdown","source":"### How are the events stored in the Database?","metadata":{}},{"cell_type":"code","source":"import sqlite3\n\ndef check_data_in_db():\n    with sqlite3.connect(\"my_agent_data.db\") as connection:\n        cursor = connection.cursor()\n        result = cursor.execute(\n            \"select app_name, session_id, author, content from events\"\n        )\n        print([_[0] for _ in result.description])\n        for each in result.fetchall():\n            print(each)\n\n\ncheck_data_in_db()","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-21T18:20:53.474066Z","iopub.execute_input":"2025-11-21T18:20:53.474391Z","iopub.status.idle":"2025-11-21T18:20:53.480625Z","shell.execute_reply.started":"2025-11-21T18:20:53.474366Z","shell.execute_reply":"2025-11-21T18:20:53.479699Z"}},"outputs":[{"name":"stdout","text":"['app_name', 'session_id', 'author', 'content']\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hi, I am Yadnywaly! What is the capital of the Japan?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Hi Yadnywaly! The capital of Japan is Tokyo.\"}], \"role\": \"model\"}')\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Your name is Yadnywaly.\"}], \"role\": \"model\"}')\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hi, I am Yadnywaly! What is the capital of the Japan?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Hi Yadnywaly! The capital of Japan is Tokyo.\"}], \"role\": \"model\"}')\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Your name is Yadnywaly.\"}], \"role\": \"model\"}')\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"What is the capital of India?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"The capital of India is New Delhi.\"}], \"role\": \"model\"}')\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Your name is Yadnywaly.\"}], \"role\": \"model\"}')\n('default', 'test-db-session-02', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-02', 'text_chat_bot', '{\"parts\": [{\"text\": \"I do not have access to your personal information, so I cannot tell you your name. \\\\n\"}], \"role\": \"model\"}')\n","output_type":"stream"}],"execution_count":12},{"cell_type":"markdown","source":"---\n## Section 4: Context Compaction\n\nAs you can see, all the events are stored in full in the session Database. For a long, complex task, this list of events can become very large, leading to slower performance and higher costs.\n\nFor this I have used **Context Compaction** feature to see **how to automatically reduce the context that's stored in the Session.**","metadata":{}},{"cell_type":"markdown","source":"### Create an App for the agent","metadata":{}},{"cell_type":"code","source":"research_app_compacting = App(\n    name=\"research_app_compacting\",\n    root_agent=chatbot_agent,\n    # This is the new part!\n    events_compaction_config=EventsCompactionConfig(\n        compaction_interval=3,  # Trigger compaction every 3 invocations\n        overlap_size=1,  # Keep 1 previous turn for context\n    ),\n)\n\ndb_url = \"sqlite:///my_agent_data.db\"  # Local SQLite file\nsession_service = DatabaseSessionService(db_url=db_url)\n\n# Create a new runner for upgraded app\nresearch_runner_compacting = Runner(\n    app=research_app_compacting, session_service=session_service\n)\n\n\nprint(\"Research App upgraded with Events Compaction!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-21T18:24:00.132620Z","iopub.execute_input":"2025-11-21T18:24:00.133046Z","iopub.status.idle":"2025-11-21T18:24:00.144469Z","shell.execute_reply.started":"2025-11-21T18:24:00.133020Z","shell.execute_reply":"2025-11-21T18:24:00.143561Z"}},"outputs":[{"name":"stdout","text":"Research App upgraded with Events Compaction!\n","output_type":"stream"},{"name":"stderr","text":"/tmp/ipykernel_48/3108707918.py:5: UserWarning: [EXPERIMENTAL] EventsCompactionConfig: This feature is experimental and may change or be removed in future versions without notice. It may introduce breaking changes at any time.\n  events_compaction_config=EventsCompactionConfig(\n","output_type":"stream"}],"execution_count":13},{"cell_type":"markdown","source":"### Running the Demo","metadata":{}},{"cell_type":"code","source":"# Turn 1\nawait run_session(\n    research_runner_compacting,\n    \"What is the latest news about AI in healthcare?\",\n    \"compaction_demo\",\n)\n\n# Turn 2\nawait run_session(\n    research_runner_compacting,\n    \"Are there any new developments in drug discovery?\",\n    \"compaction_demo\",\n)\n\n# Turn 3 - Compaction should trigger after this turn!\nawait run_session(\n    research_runner_compacting,\n    \"Tell me more about the second development you found.\",\n    \"compaction_demo\",\n)\n\n# Turn 4\nawait run_session(\n    research_runner_compacting,\n    \"Who are the main companies involved in that?\",\n    \"compaction_demo\",\n)","metadata":{"scrolled":true,"trusted":true,"execution":{"iopub.status.busy":"2025-11-21T18:24:56.973892Z","iopub.execute_input":"2025-11-21T18:24:56.974239Z","iopub.status.idle":"2025-11-21T18:25:17.662087Z","shell.execute_reply.started":"2025-11-21T18:24:56.974213Z","shell.execute_reply":"2025-11-21T18:25:17.661336Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: compaction_demo\n\nUser > What is the latest news about AI in healthcare?\ngemini-2.5-flash-lite >  Here's a summary of some of the latest and most significant news in AI in healthcare, covering various aspects:\n\n**Key Areas of Advancement and News:**\n\n*   **Drug Discovery and Development:**\n    *   **Accelerated Discovery:** AI continues to be a game-changer in identifying potential drug candidates much faster than traditional methods. Companies are using AI to analyze vast biological datasets, predict molecular interactions, and design novel compounds.\n    *   **Personalized Medicine:** AI is crucial for developing highly targeted therapies based on an individual's genetic makeup and disease profile. This includes identifying which patients are most likely to respond to specific treatments.\n    *   **Clinical Trial Optimization:** AI is being used to improve patient recruitment for clinical trials, predict trial outcomes, and analyze trial data more efficiently, potentially speeding up the approval process for new drugs.\n\n*   **Diagnostics and Imaging:**\n    *   **Enhanced Image Analysis:** AI algorithms are becoming increasingly sophisticated at detecting subtle anomalies in medical images like X-rays, CT scans, and MRIs, often assisting radiologists in identifying diseases like cancer, diabetic retinopathy, and cardiovascular conditions earlier and more accurately.\n    *   **Early Disease Detection:** Beyond imaging, AI is being developed to analyze various data points (wearables, electronic health records, genetic data) to predict the risk of developing certain diseases even before symptoms appear.\n    *   **Pathology Advancements:** AI is also making strides in analyzing pathology slides, aiding in cancer diagnosis and grading.\n\n*   **Personalized Treatment and Patient Care:**\n    *   **Treatment Recommendation Systems:** AI can analyze a patient's medical history, genetic information, and current condition to suggest the most effective treatment plans, tailored to their individual needs.\n    *   **Remote Patient Monitoring:** AI-powered tools, often integrated with wearable devices, can continuously monitor patients' vital signs and alert healthcare providers to any concerning changes, enabling proactive interventions and reducing hospital readmissions.\n    *   **Virtual Health Assistants:** Chatbots and AI-powered virtual assistants are being deployed to answer patient questions, schedule appointments, provide medication reminders, and offer basic health advice, improving accessibility and efficiency.\n\n*   **Operational Efficiency and Administrative Tasks:**\n    *   **Automating Workflows:** AI is being used to automate many administrative tasks in healthcare, such as medical coding, billing, scheduling, and prior authorization, freeing up healthcare professionals to focus on patient care.\n    *   **Predictive Analytics for Hospital Management:** AI can predict patient flow, optimize bed allocation, forecast staffing needs, and identify potential bottlenecks in hospital operations.\n    *   **Fraud Detection:** AI algorithms are being used to identify fraudulent claims and billing patterns, saving healthcare systems significant amounts of money.\n\n*   **Regulatory and Ethical Considerations:**\n    *   **AI Safety and Efficacy:** A significant ongoing discussion revolves around ensuring the safety, reliability, and ethical deployment of AI in healthcare. Regulatory bodies are actively working on frameworks to evaluate and approve AI-powered medical devices and software.\n    *   **Data Privacy and Security:** Protecting sensitive patient data is paramount. News often highlights the ongoing efforts and challenges in securing AI systems and the data they use.\n    *   **Bias in AI:** Concerns about algorithmic bias, which can lead to disparities in care for certain demographic groups, remain a critical focus. Researchers are working on developing fairer and more equitable AI models.\n\n**Recent Trends and Notable Developments (as of my last update):**\n\n*   **Generative AI in Healthcare:** While still nascent, generative AI models (like large language models) are showing promise in areas like summarizing medical literature, drafting clinical notes, and even generating synthetic patient data for research. However, their application in direct patient care requires significant validation and oversight.\n*   **Focus on Real-World Evidence:** AI is increasingly being used to analyze real-world data (from EHRs, wearables, claims data) to understand treatment effectiveness, identify adverse events, and inform clinical practice outside of traditional clinical trials.\n*   **Partnerships and Collaborations:** We continue to see strong partnerships forming between AI companies, pharmaceutical giants, academic institutions, and healthcare providers to accelerate the development and adoption of AI solutions.\n\n**Where to Find More Information:**\n\nFor the very latest news, I recommend checking reputable sources like:\n\n*   **Major Medical Journals:** JAMA, The Lancet, NEJM often publish research and commentary on AI in healthcare.\n*   **Healthcare Technology News Sites:** FierceBiotech, MedTech Dive, MobiHealthNews, Healthcare IT News.\n*   **Industry Analyst Reports:** Companies like Gartner and Forrester publish reports on AI trends in various sectors, including healthcare.\n*   **Press Releases from Leading AI and Healthcare Companies:** Companies like Google Health, Microsoft Healthcare, IBM Watson Health, and numerous AI startups frequently announce new developments.\n\nThe field of AI in healthcare is evolving at an incredible pace, so staying updated requires continuous monitoring of these sources.\n\n ### Session: compaction_demo\n\nUser > Are there any new developments in drug discovery?\ngemini-2.5-flash-lite >  Yes, absolutely! Drug discovery is one of the most dynamic and promising areas for AI in healthcare. Here are some of the key new developments and ongoing trends:\n\n**1. Generative AI for Molecule Design:**\n*   **Designing Novel Compounds from Scratch:** This is a major leap. Instead of just screening existing libraries, generative AI models can now be trained to *design* entirely new molecular structures with desired properties (e.g., binding affinity to a specific target, solubility, low toxicity). This is like having an AI chemist who can invent new drug candidates.\n*   **\"De Novo\" Drug Design:** This term refers to designing molecules from scratch, and generative AI is making this much more efficient and creative. Techniques like Generative Adversarial Networks (GANs) and Variational Autoencoders (VAEs) are being used here.\n\n**2. Enhanced Target Identification and Validation:**\n*   **Uncovering New Drug Targets:** AI can analyze vast biological datasets (genomics, proteomics, transcriptomics, clinical data) to identify novel proteins, genes, or pathways that are implicated in diseases and could serve as new drug targets.\n*   **Predicting Target Druggability:** AI can assess whether a potential target is likely to be \"druggable\" â€“ meaning a small molecule or biologic can effectively interact with it to achieve a therapeutic effect.\n\n**3. Accelerated Preclinical Testing and Optimization:**\n*   **Predicting Efficacy and Toxicity:** AI models are becoming more accurate at predicting how well a drug candidate will work and what its potential side effects might be *before* costly and time-consuming lab experiments or animal studies. This includes predicting ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) properties.\n*   **Optimizing Lead Compounds:** Once a promising candidate is found, AI can help modify its structure to improve its efficacy, reduce toxicity, and enhance its pharmacokinetic properties.\n\n**4. Revolutionizing Protein Folding and Structure Prediction:**\n*   **AlphaFold and its Successors:** DeepMind's AlphaFold has been a monumental breakthrough, accurately predicting protein 3D structures from their amino acid sequences. This is crucial because a protein's structure dictates its function and how drugs can interact with it.\n*   **Implications for Drug Design:** Understanding protein structures precisely allows for more rational drug design, enabling the creation of drugs that bind more effectively and specifically to their intended targets. Many new AI tools are building upon this capability.\n\n**5. Repurposing Existing Drugs:**\n*   **Finding New Uses for Old Drugs:** AI can sift through massive databases of existing drugs and scientific literature to identify potential new therapeutic uses for drugs already approved for other conditions. This is often faster and cheaper than developing entirely new drugs.\n*   **Accelerating Time to Market:** If a drug can be repurposed, the development and regulatory pathway can be significantly shorter.\n\n**6. Advanced Data Integration and Analysis:**\n*   **Integrating Multi-Omics Data:** AI excels at combining and analyzing diverse biological data types (genomics, epigenomics, transcriptomics, proteomics, metabolomics) with clinical data to gain a holistic understanding of disease mechanisms and drug responses.\n*   **Leveraging Real-World Data (RWD):** AI can analyze RWD from electronic health records, insurance claims, and patient registries to identify patterns, understand treatment effectiveness in real-world settings, and find new patient populations for existing drugs.\n\n**7. AI-Powered Virtual Screening:**\n*   **Faster Screening of Compound Libraries:** AI can rapidly screen vast virtual libraries of chemical compounds to identify those most likely to bind to a specific disease target, significantly narrowing down the candidates for experimental testing.\n\n**Examples of Companies and Initiatives:**\n\nMany companies, from large pharmaceutical giants (e.g., **Pfizer, Novartis, AstraZeneca**) to specialized AI-driven biotech firms (e.g., **Recursion Pharmaceuticals, Exscientia, Insilico Medicine, BenevolentAI**), are heavily investing in and reporting breakthroughs in AI-powered drug discovery. Academic institutions also play a vital role in pushing the boundaries of this research.\n\n**Challenges Remain:**\n\nDespite these advances, significant challenges persist. These include:\n*   **Data Quality and Availability:** AI models are only as good as the data they are trained on.\n*   **Validation and Reproducibility:** Ensuring that AI-generated predictions translate into real-world efficacy and safety.\n*   **Interpretability:** Understanding *why* an AI model makes a particular prediction.\n*   **Regulatory Hurdles:** Navigating the complex regulatory landscape for AI-discovered or AI-designed drugs.\n*   **Integration into Existing Workflows:** Seamlessly integrating AI tools into traditional R&D processes.\n\nIn summary, AI is not just assisting in drug discovery; it's fundamentally transforming it, making the process faster, more efficient, and enabling the exploration of previously unimaginable therapeutic avenues.\n\n ### Session: compaction_demo\n\nUser > Tell me more about the second development you found.\ngemini-2.5-flash-lite >  You're asking about the **\"Enhanced Target Identification and Validation\"** development in AI for drug discovery. This is a crucial step because, without a good target, you can't develop an effective drug.\n\nHere's a deeper dive into what this means and how AI is making an impact:\n\n**What is a Drug Target?**\n\nA drug target is typically a specific molecule in the body (usually a protein or gene) that plays a role in a disease. By designing a drug that interacts with this target (e.g., inhibiting its activity, activating it, or blocking its interaction with another molecule), we can potentially alter the course of the disease.\n\n**The Traditional Challenge:**\n\nIdentifying the \"right\" drug target has historically been a painstaking and often serendipitous process. It involved:\n*   **Deep biological understanding:** Researchers had to have a strong hypothesis about which biological pathways were disrupted in a disease.\n*   **Extensive lab work:** Experiments like gene knockouts, protein expression studies, and pathway analysis were needed to confirm a molecule's involvement in disease.\n*   **Time and cost:** This process could take years and millions of dollars, and often, promising targets turned out to be \"undruggable\" or not as critical as initially thought.\n\n**How AI is Revolutionizing Target Identification:**\n\nAI, particularly machine learning and deep learning, is a powerful tool for sifting through the overwhelming amount of biological data now available. Here's how it enhances target identification:\n\n1.  **Analyzing Vast and Complex Datasets:**\n    *   **Genomics:** AI can analyze DNA sequences to identify genes that are mutated, overexpressed, or underexpressed in diseased cells or tissues compared to healthy ones. This can point to genes driving the disease.\n    *   **Transcriptomics:** AI can analyze RNA data to understand which genes are actively being \"read\" and translated into proteins. Changes in gene expression patterns can reveal key players in disease.\n    *   **Proteomics:** AI can analyze the proteins present in cells or bodily fluids. Changes in protein levels or modifications can indicate disease states.\n    *   **Metabolomics:** AI can analyze the small molecules (metabolites) involved in cellular processes, offering insights into metabolic dysregulation in disease.\n    *   **Clinical Data:** AI can integrate these biological datasets with patient data (symptoms, treatment responses, medical history) to find correlations between specific biological molecules and disease outcomes.\n\n2.  **Uncovering Novel and Unexpected Pathways:**\n    *   **Pattern Recognition:** AI algorithms are excellent at finding complex patterns and correlations within these massive datasets that human researchers might miss. This can reveal entirely new biological pathways or previously unrecognized roles for known molecules in disease.\n    *   **Network Analysis:** AI can build sophisticated biological networks, showing how different genes, proteins, and pathways interact. By analyzing these networks, AI can pinpoint critical \"nodes\" or \"hubs\" that are central to disease progression and thus, good drug targets.\n\n3.  **Predicting Target \"Druggability\":**\n    *   **Structure Prediction:** As mentioned with AlphaFold, AI can predict protein structures. Knowing the 3D shape of a target protein is essential for designing molecules that can bind to it.\n    *   **Binding Site Identification:** AI can identify potential \"pockets\" or \"sites\" on a protein where a drug molecule could attach and exert its effect.\n    *   **Existing Drug Knowledge:** AI can leverage databases of known drugs and their targets to infer which types of molecules are likely to bind to a new target.\n\n4.  **Prioritizing Targets:**\n    *   **Ranking Potential Targets:** Given the sheer number of potential targets AI might uncover, it can rank them based on various criteria: strength of association with disease, predicted druggability, novelty, and potential for therapeutic impact. This helps researchers focus their limited resources on the most promising candidates.\n\n**Examples of AI in Action:**\n\n*   **Identifying cancer drivers:** AI analyzing genomic mutations in tumors to find specific genes that, when targeted, could halt cancer growth.\n*   **Uncovering targets for neurodegenerative diseases:** AI analyzing protein aggregation patterns and genetic predispositions to identify novel therapeutic targets for Alzheimer's or Parkinson's.\n*   **Finding targets for rare diseases:** AI sifting through limited patient data and genetic information to pinpoint elusive targets in diseases where research has been stalled.\n\n**In essence, AI acts as a powerful \"biological detective\" and \"hypothesis generator.\"** It takes the noisy, complex, and vast landscape of biological information and distills it into a set of high-probability, actionable drug targets that researchers can then pursue with experimental validation and drug development. This significantly speeds up the front end of the drug discovery pipeline.\n\n ### Session: compaction_demo\n\nUser > Who are the main companies involved in that?\ngemini-2.5-flash-lite >  You're interested in the players driving AI-powered target identification and validation. This is a rapidly evolving space, and it involves a mix of established pharmaceutical giants and innovative AI-focused biotech companies.\n\nHere are the main categories of companies and some prominent examples:\n\n**1. AI-Native Drug Discovery Companies (The Innovators):**\nThese companies were founded with AI at their core and often focus specifically on generating novel targets and drug candidates using their proprietary AI platforms.\n\n*   **Exscientia:** One of the pioneers. They use AI for \"end-to-end\" drug discovery, including identifying novel targets and designing molecules. They have multiple AI-designed drugs in clinical trials.\n*   **Recursion Pharmaceuticals:** Uses AI and automation to map cellular disease biology. Their platform identifies targets by observing how disease cells respond to various genetic and chemical perturbations, all analyzed by AI.\n*   **Insilico Medicine:** Known for its \"AI-driven drug discovery\" platform that identifies targets, designs molecules, and even predicts clinical trial outcomes. They have advanced multiple AI-discovered drugs into human trials.\n*   **BenevolentAI:** Focuses on integrating vast amounts of scientific literature, patents, and clinical data using AI to uncover novel targets and generate new hypotheses for disease intervention.\n*   **Atomwise:** Specializes in using deep learning for small molecule drug discovery, including identifying potential targets and predicting drug-target interactions.\n*   **SchrÃ¶dinger:** While also a leader in physics-based computational chemistry, SchrÃ¶dinger heavily incorporates machine learning and AI into its platform for target identification and property prediction.\n\n**2. Large Pharmaceutical Companies (The Established Players):**\nThese companies have vast resources and deep biological expertise. They are increasingly integrating AI into their existing R&D pipelines, often through internal AI divisions, partnerships, or acquisitions.\n\n*   **Pfizer:** Actively uses AI for various aspects of R&D, including target identification, drug design, and clinical trial optimization.\n*   **Novartis:** Has made significant investments in AI and machine learning for drug discovery, including target validation.\n*   **AstraZeneca:** Leverages AI and data science across its R&D, from identifying novel targets to predicting patient responses.\n*   **Gilead Sciences:** Employs AI and machine learning to accelerate target identification and understand disease biology.\n*   **Merck (MSD):** Investing in AI to enhance its drug discovery efforts, including finding new therapeutic targets.\n*   **Roche/Genentech:** Strong emphasis on data science and AI to drive innovation in target identification and personalized medicine.\n\n**3. Technology Giants with Healthcare Arms:**\nWhile not directly discovering drugs, these companies provide the foundational AI technologies and platforms that power many of the above.\n\n*   **Google (Alphabet - Google Health, DeepMind):** DeepMind's AlphaFold is a revolutionary tool for understanding protein structures, which is critical for target validation and drug design. Google's AI platforms are also used for analyzing healthcare data.\n*   **Microsoft (Microsoft Healthcare):** Provides cloud computing power and AI tools that enable life sciences companies to process massive datasets for target identification and drug discovery.\n*   **IBM (IBM Watson Health - though its focus has shifted):** Historically, Watson was applied to drug discovery, aiming to help identify targets and analyze research. While its role has evolved, the principles of using AI for data analysis remain relevant.\n\n**4. Academic Institutions and Research Consortia:**\nMany universities and research centers are at the forefront of developing new AI methodologies for biological discovery, including target identification. They often collaborate with industry.\n\n**How They Interact:**\n\n*   **Partnerships & Collaborations:** Many AI-native companies partner with Big Pharma to leverage their biological expertise and clinical trial infrastructure, while Big Pharma gains access to cutting-edge AI platforms.\n*   **Acquisitions:** Larger companies sometimes acquire smaller AI biotech firms to integrate their technology and talent.\n*   **Internal Development:** Big Pharma is increasingly building its own in-house AI and data science teams.\n\nThe key takeaway is that the landscape is a blend of specialized AI companies pushing the boundaries and established pharmaceutical leaders adopting and integrating these technologies to stay competitive and accelerate their drug development pipelines.\n","output_type":"stream"}],"execution_count":14},{"cell_type":"markdown","source":"### Verifying Compaction in the Session History","metadata":{}},{"cell_type":"code","source":"# Get the final session state\nfinal_session = await session_service.get_session(\n    app_name=research_runner_compacting.app_name,\n    user_id=USER_ID,\n    session_id=\"compaction_demo\",\n)\n\nprint(\"--- Searching for Compaction Summary Event ---\")\nfound_summary = False\nfor event in final_session.events:\n    # Compaction events have a 'compaction' attribute\n    if event.actions and event.actions.compaction:\n        print(\"\\n SUCCESS! Found the Compaction Event:\")\n        print(f\"  Author: {event.author}\")\n        print(f\"\\n Compacted information: {event}\")\n        found_summary = True\n        break\n\nif not found_summary:\n    print(\n        \"\\n No compaction event found. Try increasing the number of turns in the demo.\"\n    )","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-21T18:26:48.721274Z","iopub.execute_input":"2025-11-21T18:26:48.721616Z","iopub.status.idle":"2025-11-21T18:26:48.734087Z","shell.execute_reply.started":"2025-11-21T18:26:48.721593Z","shell.execute_reply":"2025-11-21T18:26:48.733228Z"}},"outputs":[{"name":"stdout","text":"--- Searching for Compaction Summary Event ---\n\n SUCCESS! Found the Compaction Event:\n  Author: user\n\n Compacted information: model_version=None content=None grounding_metadata=None partial=None turn_complete=None finish_reason=None error_code=None error_message=None interrupted=None custom_metadata=None usage_metadata=None live_session_resumption_update=None input_transcription=None output_transcription=None avg_logprobs=None logprobs_result=None cache_metadata=None citation_metadata=None invocation_id='bee6e4cc-f965-428a-8cbd-7ba8d78470d1' author='user' actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction={'start_timestamp': 1763749497.003937, 'end_timestamp': 1763749507.083113, 'compacted_content': {'parts': [{'function_call': None, 'code_execution_result': None, 'executable_code': None, 'file_data': None, 'function_response': None, 'inline_data': None, 'text': 'The user is asking about the latest news in AI in healthcare. The AI provided a comprehensive overview covering:\\n\\n*   **Key Areas of Advancement:** Drug discovery, diagnostics/imaging, personalized treatment, operational efficiency, and regulatory/ethical considerations.\\n*   **Recent Trends:** Generative AI in healthcare, real-world evidence analysis, and industry partnerships.\\n*   **Information Sources:** Recommendations for staying updated through medical journals, tech news sites, analyst reports, and company press releases.\\n\\nThe user then specifically asked about new developments in drug discovery, to which the AI responded with:\\n\\n*   **Generative AI for Molecule Design:** Creating novel drug compounds from scratch.\\n*   **Enhanced Target Identification:** Identifying new disease targets using diverse biological data.\\n*   **Accelerated Preclinical Testing:** Predicting drug efficacy and toxicity.\\n*   **Protein Folding:** Leveraging breakthroughs like AlphaFold for structure prediction.\\n*   **Drug Repurposing:** Finding new uses for existing drugs.\\n*   **Advanced Data Integration:** Combining multi-omics and real-world data.\\n*   **AI-Powered Virtual Screening:** Rapidly screening compound libraries.\\n*   **Examples of Companies:** Mentioned both large pharmaceutical companies and specialized AI biotech firms.\\n*   **Remaining Challenges:** Data quality, validation, interpretability, regulatory hurdles, and integration.\\n\\nFinally, the user inquired for more details on \"Enhanced Target Identification and Validation,\" which the AI elaborated on by:\\n\\n*   **Defining Drug Target:** Explaining what a drug target is and the traditional challenges in finding one.\\n*   **AI\\'s Role:** Detailing how AI analyzes vast datasets (genomics, transcriptomics, proteomics, metabolomics, clinical data) to uncover novel pathways, predict target druggability (using structure prediction and binding site identification), and prioritize potential targets.\\n*   **Illustrative Examples:** Providing examples in cancer, neurodegenerative diseases, and rare diseases.\\n*   **AI\\'s Function:** Describing AI as a \"biological detective\" and \"hypothesis generator\" that accelerates the early stages of drug discovery.\\n\\n**Key Information and Decisions:**\\n\\n*   The AI successfully identified and summarized key advancements in AI in healthcare and specifically in drug discovery.\\n*   The AI provided detailed explanations for specific developments, answering user follow-up questions.\\n*   The conversation is focused on providing information about AI in healthcare and drug discovery.\\n\\n**Unresolved Questions or Tasks:**\\n\\nThere are no outstanding questions or tasks from the user. The conversation has been purely informational.', 'thought': None, 'thought_signature': None, 'video_metadata': None}], 'role': 'model'}}, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None) long_running_tool_ids=set() branch=None id='cb087dd9-15c8-46a7-91dc-f0ed0cbd288d' timestamp=1763749515.18979\n","output_type":"stream"}],"execution_count":15},{"cell_type":"markdown","source":"---\n## Section 5: Working with Session State","metadata":{}},{"cell_type":"code","source":"# Define scope levels for state keys \nUSER_NAME_SCOPE_LEVELS = (\"temp\", \"user\", \"app\")\n\n\n# This demonstrates how tools can write to session state using tool_context.\n# The 'user:' prefix indicates this is user-specific data.\ndef save_userinfo(\n    tool_context: ToolContext, user_name: str, country: str\n) -> Dict[str, Any]:\n    \"\"\"\n    Tool to record and save user name and country in session state.\n\n    Args:\n        user_name: The username to store in session state\n        country: The name of the user's country\n    \"\"\"\n    # Write to session state using the 'user:' prefix for user data\n    tool_context.state[\"user:name\"] = user_name\n    tool_context.state[\"user:country\"] = country\n\n    return {\"status\": \"success\"}\n\n\n# This demonstrates how tools can read from session state.\ndef retrieve_userinfo(tool_context: ToolContext) -> Dict[str, Any]:\n    \"\"\"\n    Tool to retrieve user name and country from session state.\n    \"\"\"\n    # Read from session state\n    user_name = tool_context.state.get(\"user:name\", \"Username not found\")\n    country = tool_context.state.get(\"user:country\", \"Country not found\")\n\n    return {\"status\": \"success\", \"user_name\": user_name, \"country\": country}\n\n\nprint(\"Tools created.\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-21T18:30:23.228112Z","iopub.execute_input":"2025-11-21T18:30:23.228995Z","iopub.status.idle":"2025-11-21T18:30:23.235963Z","shell.execute_reply.started":"2025-11-21T18:30:23.228967Z","shell.execute_reply":"2025-11-21T18:30:23.235114Z"}},"outputs":[{"name":"stdout","text":"Tools created.\n","output_type":"stream"}],"execution_count":16},{"cell_type":"markdown","source":"### Creating an Agent with Session State Tools","metadata":{}},{"cell_type":"code","source":"# Configuration\nAPP_NAME = \"default\"\nUSER_ID = \"default\"\nMODEL_NAME = \"gemini-2.5-flash-lite\"\n\n# Create an agent with session state tools\nroot_agent = LlmAgent(\n    model=Gemini(model=\"gemini-2.5-flash-lite\", retry_options=retry_config),\n    name=\"text_chat_bot\",\n    description=\"\"\"A text chatbot.\n    Tools for managing user context:\n    * To record username and country when provided use `save_userinfo` tool. \n    * To fetch username and country when required use `retrieve_userinfo` tool.\n    \"\"\",\n    tools=[save_userinfo, retrieve_userinfo],  # Provide the tools to the agent\n)\n\n# Set up session service and runner\nsession_service = InMemorySessionService()\nrunner = Runner(agent=root_agent, session_service=session_service, app_name=\"default\")\n\nprint(\"Agent with session state tools initialized!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-21T18:30:50.482924Z","iopub.execute_input":"2025-11-21T18:30:50.483225Z","iopub.status.idle":"2025-11-21T18:30:50.491456Z","shell.execute_reply.started":"2025-11-21T18:30:50.483203Z","shell.execute_reply":"2025-11-21T18:30:50.490580Z"}},"outputs":[{"name":"stdout","text":"Agent with session state tools initialized!\n","output_type":"stream"}],"execution_count":17},{"cell_type":"markdown","source":"### Testing Session State ","metadata":{}},{"cell_type":"code","source":"# Test conversation demonstrating session state\nawait run_session(\n    runner,\n    [\n        \"Hi there, how are you doing today? What is my name?\",  # Agent shouldn't know the name yet\n        \"My name is Yadnywalky. I'm from India.\",  # Provide name - agent should save it\n        \"What is my name? Which country am I from?\",  # Agent should recall from session state\n    ],\n    \"state-demo-session\",\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-21T18:31:50.775382Z","iopub.execute_input":"2025-11-21T18:31:50.775785Z","iopub.status.idle":"2025-11-21T18:31:53.285564Z","shell.execute_reply.started":"2025-11-21T18:31:50.775760Z","shell.execute_reply":"2025-11-21T18:31:53.284710Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: state-demo-session\n\nUser > Hi there, how are you doing today? What is my name?\ngemini-2.5-flash-lite >  Hello! I'm doing great. I'd love to tell you your name, but I don't have it stored. If you tell me your name and country, I can save it for you.\n\nUser > My name is Yadnywalky. I'm from India.\n","output_type":"stream"},{"name":"stderr","text":"WARNING:google_genai.types:Warning: there are non-text parts in the response: ['function_call'], returning concatenated text result from text parts. Check the full candidates.content.parts accessor to get the full model response.\n","output_type":"stream"},{"name":"stdout","text":"gemini-2.5-flash-lite >  It is nice to meet you, Yadnywalky! I have saved that you are from India.\n\nUser > What is my name? Which country am I from?\n","output_type":"stream"},{"name":"stderr","text":"WARNING:google_genai.types:Warning: there are non-text parts in the response: ['function_call'], returning concatenated text result from text parts. Check the full candidates.content.parts accessor to get the full model response.\n","output_type":"stream"},{"name":"stdout","text":"gemini-2.5-flash-lite >  Your name is Yadnywalky and you are from India.\n","output_type":"stream"}],"execution_count":18},{"cell_type":"markdown","source":"### Inspecting Session State","metadata":{}},{"cell_type":"code","source":"# Retrieve the session and inspect its state\nsession = await session_service.get_session(\n    app_name=APP_NAME, user_id=USER_ID, session_id=\"state-demo-session\"\n)\n\nprint(\"Session State Contents:\")\nprint(session.state)\nprint(\"\\n Notice the 'user:name' and 'user:country' keys storing our data!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-21T18:32:28.400248Z","iopub.execute_input":"2025-11-21T18:32:28.400862Z","iopub.status.idle":"2025-11-21T18:32:28.407011Z","shell.execute_reply.started":"2025-11-21T18:32:28.400832Z","shell.execute_reply":"2025-11-21T18:32:28.406054Z"}},"outputs":[{"name":"stdout","text":"Session State Contents:\n{'user:name': 'Yadnywalky', 'user:country': 'India'}\n\n Notice the 'user:name' and 'user:country' keys storing our data!\n","output_type":"stream"}],"execution_count":19},{"cell_type":"markdown","source":"### Session State Isolation","metadata":{}},{"cell_type":"code","source":"# Start a completely new session - the agent won't know my name\nawait run_session(\n    runner,\n    [\"Hi there, how are you doing today? What is my name?\"],\n    \"new-isolated-session\",\n)\n","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-21T18:34:06.783269Z","iopub.execute_input":"2025-11-21T18:34:06.783606Z","iopub.status.idle":"2025-11-21T18:34:07.621925Z","shell.execute_reply.started":"2025-11-21T18:34:06.783582Z","shell.execute_reply":"2025-11-21T18:34:07.621045Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: new-isolated-session\n\nUser > Hi there, how are you doing today? What is my name?\ngemini-2.5-flash-lite >  Hello! I'm doing well, thank you for asking. I can't recall your name at the moment. If you tell me your name and country, I can save it for you.\n","output_type":"stream"}],"execution_count":20},{"cell_type":"markdown","source":"### Cross-Session State Sharing","metadata":{}},{"cell_type":"code","source":"# Check the state of the new session\nsession = await session_service.get_session(\n    app_name=APP_NAME, user_id=USER_ID, session_id=\"new-isolated-session\"\n)\n\nprint(\"New Session State:\")\nprint(session.state)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-21T18:34:48.647504Z","iopub.execute_input":"2025-11-21T18:34:48.648267Z","iopub.status.idle":"2025-11-21T18:34:48.653145Z","shell.execute_reply.started":"2025-11-21T18:34:48.648241Z","shell.execute_reply":"2025-11-21T18:34:48.652350Z"}},"outputs":[{"name":"stdout","text":"New Session State:\n{'user:name': 'Yadnywalky', 'user:country': 'India'}\n","output_type":"stream"}],"execution_count":21},{"cell_type":"markdown","source":"---\n\n## ðŸ§¹ Cleanup","metadata":{}},{"cell_type":"code","source":"# Clean up any existing database to start fresh \nimport os\n\nif os.path.exists(\"my_agent_data.db\"):\n    os.remove(\"my_agent_data.db\")\nprint(\"Cleaned up old database files\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-21T18:35:05.282384Z","iopub.execute_input":"2025-11-21T18:35:05.283192Z","iopub.status.idle":"2025-11-21T18:35:05.288231Z","shell.execute_reply.started":"2025-11-21T18:35:05.283164Z","shell.execute_reply":"2025-11-21T18:35:05.287177Z"}},"outputs":[{"name":"stdout","text":"Cleaned up old database files\n","output_type":"stream"}],"execution_count":22},{"cell_type":"markdown","source":"\n\n## âœ… Congratulations! ðŸŽ‰","metadata":{}}]}